Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Advanced Incubation Solution Introduced for Cell-Based Research

By BiotechDaily International staff writers
Posted on 31 Jan 2013
Image: The Thermo Scientific Cytomat 10 automated incubator (Photo courtesy of Thermo Fisher).
Image: The Thermo Scientific Cytomat 10 automated incubator (Photo courtesy of Thermo Fisher).
An automated incubator and storage module provides superior cell growth and assay incubation and a reliable thermal decontamination routine.

Thermo Fisher Scientific (Waltham, MA, USA) has now introduced the new Thermo Scientific Cytomat 10, an automated incubator and storage module designed to provide superior environmental control for cell growth and assay incubations in laboratories performing high-throughput cell biology or screening. The Cytomat 10 provides a fast plate access time of less than 10 seconds. Additionally, multiple transfer positions and an under-bench version allow flexible incubator placement within the laboratory. As the first generation of automated incubator with a fully validated thermal decontamination system, the Thermo Scientific Cytomat 10 is designed to significantly decrease the risk of contamination and reduce assay variability.

Utilizing more than 40 years of experience in CO2 incubator technology, the Thermo Scientific Cytomat 10 design provides scientists with a reliable, robust incubation unit for precious cell cultures and assays. The design virtually eliminates recovery times with a heated automatic access door, with small opening. The efficient thermal disinfection method practically eliminates germs and spore suspensions, even in areas difficult to reach via manual cleaning. Based on the trusted ContraCon Routine of the Thermo Scientific HERAcell incubators, the Cytomat 10’s decontamination is carried out in wet conditions at 90 °C, leaving incubators virtually residue-free. The Thermo Scientific Cytomat 10 incorporates humidity control via an external water reservoir, reducing the risk of contamination from an internal source and the need for repetitive incubator access.

As a flexible incubation unit, the Cytomat 10 incorporates the Thermo Scientific internally automated PSS (Plate Shuttle System) to serve multiple access and loading positions. Cytomat 10 includes an LCD monitor for incubation parameters and full text read-out messaging to inform the user of temperature, humidity, and gaseous atmosphere level changes. The unit can also be seamlessly integrated with existing automated assay hardware.

Related Links:

Thermo Fisher Scientific, Inc.
Thermo Scientific Cytomat 10





Channels

Genomics/Proteomics

view channel
Image: The bone marrow of mice with normal ether lipid production (top) contains more white blood cells than are found in the bone marrow of mice with ether lipid deficiency (bottom) (Photo courtesy of Washington University School of Medicine).

Inactivating Fatty Acid Synthase Reduces Inflammation by Interfering with Neutrophil Membrane Function

The enzyme fatty acid synthase (FAS) was shown to regulate inflammation by sustaining neutrophil viability through modulation of membrane phospholipid composition. Neutrophils are the most abundant... Read more

Drug Discovery

view channel
Image: Researchers have attached two drugs—TRAIL and Dox—onto graphene strips. TRAIL is most effective when delivered to the external membrane of a cancer cell, while Dox is most effective when delivered to the nucleus, so the researchers designed the system to deliver the drugs sequentially, with each drug hitting a cancer cell where it will do the most damage (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Anticancer Drug Delivery System Utilizes Graphene Strip Transporters

The ongoing search by cancer researchers for targeted drug delivery systems has generated a novel approach that uses graphene strips to transport simultaneously the anticancer agents TRAIL (tumor necrosis... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Therapeutics

view channel
Image: Cancer cells infected with tumor-targeted oncolytic virus (red). Green indicates alpha-tubulin, a cell skeleton protein. Blue is DNA in the cancer cell nuclei (Photo courtesy of Dr. Rathi Gangeswaran, Bart’s Cancer Institute).

Innovative “Viro-Immunotherapy” Designed to Kill Breast Cancer Cells

A leading scientist has devised a new treatment that employs viruses to kill breast cancer cells. The research could lead to a promising “viro-immunotherapy” for patients with triple-negative breast cancer,... Read more

Business

view channel

Biotech Acquisition Designed to Accelerate the Development and Marketing of Immunosequencing Applications

Adaptive Biotechnologies Corp. (Seattle, WA, USA), a developer of next-generation sequencing (NGS) to profile T-cell and B-cell receptors, has acquired of Sequenta, Inc. (South San Francisco, CA, USA), which is expected to expedite and expand the use of innovative immunosequencing technology for researchers and clinicians... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.